Qilu Pharmaceutical

Qilu Pharmaceutical is a leading vertically integrated Chinese pharmaceutical company headquartered in Jinan, Shandong. Founded in 1958, the company has evolved from a small vaccine plant into a global powerhouse specializing in the development, manufacturing, and marketing of both generic and innovative medicines. Its portfolio spans oncology, anti-infectives, cardiovascular, neurological, and ophthalmological therapeutic areas. Qilu is particularly recognized for its robust pipeline of biosimilars and its increasing focus on novel biologics, including bispecific antibodies and ADCs. With multiple R&D centers in China and the United States, the group maintains a significant international footprint, exporting products to over 90 countries and regions.